ET-002

N/A

Report date: 2023/04/25 09:11:29

Base Information

Drug NameET-002
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionComplement factor D inhibitors
TargetsComplement factor D
Therapy Area/IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1Lupus Erythematosus, Systemic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndocrine Technology LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocrine Technology LLC
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1Lupus Erythematosus, Systemic +[6] 

Other Information

ATC CodeN/A
Related LinksN/A